Atrial fibrillation is the most common of the cardiac arrhythmias and affects nearly 3 million patients in the United States. It is expected that patients with atrial fibrillation will grow dramatically, affecting 16 million patients by 2050. Treating AFib is complex and expensive; the forecasted expenditure by 2050 is $26 billion driven primarily by hospital based services. In fact, the estimated U.S. ablation volume is expected to increase 26% between 2011 and 2021 – with the majority of growth occurring on the outpatient procedure basis.
In this case study West Michigan Heart, experiencing significant operations problems primarily categorized by access and backlog issues, engaged MedAxiom to re-design the care delivery model with particular emphasis on effectively and efficiently managing atrial fibrillation patients.